drugset

drugset / Trial / NCT02047162

Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

NCT02047162 ↗

Completed 400 enrolled Centers for Disease Control and Prevention Health Oriented Preventive Education · collab Procter and Gamble · collab

RandomizedParallel-groupQuadruple-blindHealth-services research

Summary

The purpose of this study is to learn whether bismuth subsalicylate can reduce use of antibiotics among adults with diarrhea in Pakistan.

Timeline

Start: 2014-05
Primary completion: 2014-09
Completion: 2014-09

Publications

Bowen A, Agboatwalla M, Pitz A, Salahuddin S, Brum J, Plikaytis B. Effect of Bismuth Subsalicylate vs Placebo on Use of Antibiotics Among Adult Outpatients With Diarrhea in Pakistan: A Randomized Clinical Trial. JAMA Netw Open. 2019 Aug 2;2(8):e199441. doi: 10.1001/jamanetworkopen.2019.9441.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bismuth subsalicylate	Small molecule	262 mg	—

Indications